Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,486 papers from all fields of science
Search
Sign In
Create Free Account
DU 6859A
Known as:
DU-6859A
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Spiro Compounds
sitafloxacin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Therapeutic effects of a new quinolone, DU-6859a, on polymicrobial infections in a newly designed model of rat uterine endometritis.
H. Mikamo
,
K. Kawazoe
,
Y. Sato
,
K. Izumi
,
T. Tamaya
Journal of Antimicrobial Chemotherapy
1998
Corpus ID: 6857142
We evaluated the efficacy of a new quinolone, DU-6859a, using a new model of rat uterine endometritis. Rats were infected with…
Expand
Review
1998
Review
1998
[Chemotherapeutic agents under study].
S. Kawahara
Nihon rinsho. Japanese journal of clinical…
1998
Corpus ID: 26549278
The development of new drugs with strong antituberculous activity and fewer side effects which are not cross-resistant to…
Expand
1997
1997
Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the…
T. Deguchi
,
M. Yasuda
,
+5 authors
Y. Kawada
Journal of Antimicrobial Chemotherapy
1997
Corpus ID: 13429839
The in-vitro antimicrobial activity of DU-6859a, a new fluoroquinolone, was tested against 55 clinical isolates of Neisseria…
Expand
1997
1997
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates
E. Goldstein
,
D. Citron
,
S. Gerardo
,
M. Hudspeth
,
C. V. Merriam
Antimicrobial Agents and Chemotherapy
1997
Corpus ID: 20614001
The activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against bite wound isolates were determined…
Expand
Highly Cited
1996
Highly Cited
1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci
M. Visalli
,
M. Jacobs
,
P. Appelbaum
Antimicrobial Agents and Chemotherapy
1996
Corpus ID: 25687291
MIC and time-kill methods were used to test the activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime…
Expand
1996
1996
Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method.
M. Tanaka
,
K. Hoshino
,
+5 authors
T. Nishino
Journal of Antimicrobial Chemotherapy
1996
Corpus ID: 37029558
The effect of growth conditions on the antibacterial activity of DU-6859a against Staphylococcus auerus, Escherichia coli, and…
Expand
Highly Cited
1995
Highly Cited
1995
Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa
A. Kitamura
,
K. Hoshino
,
Y. Kimura
,
I. Hayakawa
,
K. Sato
Antimicrobial Agents and Chemotherapy
1995
Corpus ID: 11308941
Inhibitory effects of five quinolones against DNA gyrases purified from four quinolone-resistant clinical isolates of Pseudomonas…
Expand
1995
1995
Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
I. Morrissey
,
J. Smith
Journal of Medical Microbiology
1995
Corpus ID: 36167397
The bactericidal activity of two new 4-quinolones, DU-6859a and DV-7751a, was investigated against strains of Escherichia coli…
Expand
1994
1994
Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci
V. Korten
,
J. Tomayko
,
B. Murray
Antimicrobial Agents and Chemotherapy
1994
Corpus ID: 25396038
The in vitro activity of DU-6859a (DU), a new fluoroquinolone agent, was evaluated against 233 gram-positive cocci and was…
Expand
1993
1993
In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone
S. Marshall
,
R. Jones
Antimicrobial Agents and Chemotherapy
1993
Corpus ID: 26856403
DU-6859a was tested against 844 recent clinical isolates (most from bacteremias) by using reference MIC determination procedures…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE